Fertility-sparing treatment in early endometrial cancer: current state and future strategies
Endometrial cancer (EC) is the fifth most common cancer in women worldwide. Global estimates show rising incidence rates in both developed and developing countries. Most women are diagnosed postmenopausal, but 14-25% of patients are premenopausal and 5% are under 40 years of age. Established risk fa...
Saved in:
Main Authors: | Andreas Obermair (Author), Eva Baxter (Author), Donal J. Brennan (Author), Jessica N. McAlpine (Author), Jennifer J. Muellerer (Author), Frédéric Amant (Author), Mignon D. J. M. van Gent (Author), Robert L. Coleman (Author), Shannon N. Westin (Author), Melinda S. Yates (Author), Camilla Krakstad (Author), Monika Janda (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Obstetrics and Gynecology,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
by: A.M. Newtson, et al.
Published: (2017) -
New insights into fertility-sparing treatment of endometrial cancer
by: Luca Giannella, et al.
Published: (2024) -
Can a symptom checklist improve the triage of patients following successful endometrial cancer treatment?
by: Yang Peng, et al.
Published: (2020) -
Paucity of data evaluating patient centred outcomes following sentinel lymph node dissection in endometrial cancer: A systematic review
by: Helena M. Obermair, et al.
Published: (2021) -
Fertility-Sparing Treatment in Endometrial Cancer
by: Yenrudee Poomtavorn
Published: (2019)